119 related articles for article (PubMed ID: 12833018)
1. Disseminated vascular papules in an immunodeficient patient being treated with granulocyte colony-stimulating factor.
Lenczowski JM; Cassarino DS; Jain A; Turner ML
J Am Acad Dermatol; 2003 Jul; 49(1):105-8. PubMed ID: 12833018
[No Abstract] [Full Text] [Related]
2. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
[TBL] [Abstract][Full Text] [Related]
3. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
5. [Neutropenia in patient with X-linked hyper-IgM syndrome].
Iwata M; Nunoi H; Nonoyama S; Shimadzu M; Higuchi S; Yanabe Y; Migita M; Adachi N; Matsuda I
Rinsho Ketsueki; 1995 Oct; 36(10):1223-9. PubMed ID: 8531335
[TBL] [Abstract][Full Text] [Related]
6. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
Atarod L; Aghamohammadi A; Moin M; Kanegane H; Rezaei N; Rezaei Kalantari K; Amirzagar AA; Futatani T; Miyawaki M
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):37-40. PubMed ID: 17303928
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
[TBL] [Abstract][Full Text] [Related]
9. Pyogenic granuloma-like lesions associated with topical retinoid therapy.
Baran R
J Am Acad Dermatol; 2002 Dec; 47(6):970. PubMed ID: 12451395
[No Abstract] [Full Text] [Related]
10. Severe chronic neutropenia--a case report.
Bahl S; Vurgese T; Parappil A
Indian J Pathol Microbiol; 2004 Oct; 47(4):523-5. PubMed ID: 16295383
[TBL] [Abstract][Full Text] [Related]
11. Pyogenic granulomas following topical application of tretinoin.
Teknetzis A; Ioannides D; Vakali G; Lefaki I; Minas A
J Eur Acad Dermatol Venereol; 2004 May; 18(3):337-9. PubMed ID: 15096149
[TBL] [Abstract][Full Text] [Related]
12. Severe reversible thrombocytopenia caused by recombinant human granulocyte colony-stimulating factor in an AIDS patient receiving chronic ganciclovir therapy.
Holtzer CD; Stanley HD; Jacobson MA
AIDS; 1997 Sep; 11(11):1403-5. PubMed ID: 9302457
[No Abstract] [Full Text] [Related]
13. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
14. [Cyclic neutropenia: a de novo case and treatment with G-CSF].
Iglesias Blázquez C; Mata Zubillaga D; Ledesma Benítez I; Martínez Badás JP; Marugán de Miguelsanz JM
An Pediatr (Barc); 2009 Apr; 70(4):403-5. PubMed ID: 19268636
[No Abstract] [Full Text] [Related]
15. Levamisole therapy for cellular immunologic deficiency with high IgE values.
Vanheule R; De Cree J; Adriaenssens K; De Hauwere R
Acta Paediatr Belg; 1976; 29(1):41-6. PubMed ID: 1015292
[No Abstract] [Full Text] [Related]
16. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with "idiopathic neonatal neutropenia": a randomized, placebo-controlled trial.
Juul SE; Christensen RD
J Perinatol; 2003 Sep; 23(6):493-7. PubMed ID: 13679938
[TBL] [Abstract][Full Text] [Related]
17. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
Timmer-Bonte JN; Tjan-Heijnen VC
Anticancer Drugs; 2006 Sep; 17(8):881-9. PubMed ID: 16940798
[TBL] [Abstract][Full Text] [Related]
18. [Letter: IgM monoclonal dysglobulinemia preceded by an IgG monoclonal gammopathy].
Potier J; Thomas M; Laniece M; Ramon P; Jame P
Nouv Presse Med; 1976 Jan; 5(5):274-5. PubMed ID: 1264690
[No Abstract] [Full Text] [Related]
19. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
20. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
